Correlation Between Nuvectis Pharma and AgeX Therapeutics
Can any of the company-specific risk be diversified away by investing in both Nuvectis Pharma and AgeX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nuvectis Pharma and AgeX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nuvectis Pharma and AgeX Therapeutics, you can compare the effects of market volatilities on Nuvectis Pharma and AgeX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nuvectis Pharma with a short position of AgeX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nuvectis Pharma and AgeX Therapeutics.
Diversification Opportunities for Nuvectis Pharma and AgeX Therapeutics
0.44 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Nuvectis and AgeX is 0.44. Overlapping area represents the amount of risk that can be diversified away by holding Nuvectis Pharma and AgeX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AgeX Therapeutics and Nuvectis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nuvectis Pharma are associated (or correlated) with AgeX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AgeX Therapeutics has no effect on the direction of Nuvectis Pharma i.e., Nuvectis Pharma and AgeX Therapeutics go up and down completely randomly.
Pair Corralation between Nuvectis Pharma and AgeX Therapeutics
If you would invest 837.00 in Nuvectis Pharma on August 25, 2024 and sell it today you would lose (327.00) from holding Nuvectis Pharma or give up 39.07% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 0.37% |
| Values | Daily Returns |
Nuvectis Pharma vs. AgeX Therapeutics
Performance |
| Timeline |
| Nuvectis Pharma |
| AgeX Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Nuvectis Pharma and AgeX Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Nuvectis Pharma and AgeX Therapeutics
The main advantage of trading using opposite Nuvectis Pharma and AgeX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nuvectis Pharma position performs unexpectedly, AgeX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AgeX Therapeutics will offset losses from the drop in AgeX Therapeutics' long position.| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
| AgeX Therapeutics vs. MAIA Biotechnology | AgeX Therapeutics vs. Larimar Therapeutics | AgeX Therapeutics vs. Lyra Therapeutics | AgeX Therapeutics vs. Lineage Cell Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |